|
2024-12-03 |
2024-12-02 |
S
Sale
|
Herskowitz Neil
Non-Executive Director
|
23
-19.2%
2.00
USD 46
|
23
-19.2%
|
2.00
|
USD 46
|
|
|
2024-11-07 |
2024-11-05 |
S
Sale
|
KRANZLER JAY D
Non-Executive Director
|
61
-9.8%
2.24
USD 137
|
61
-9.8%
|
2.24
|
USD 137
|
|
|
2024-10-01 |
2024-09-30 |
B
Purchase
|
KRANZLER JAY D
Non-Executive Director
|
497
+404.1%
2.50
USD 1,243
|
497
+404.1%
|
2.50
|
USD 1,243
|
|
|
2024-10-01 |
2024-09-27 |
B
Purchase
|
KRANZLER JAY D
Non-Executive Director
|
3
+2.5%
2.40
USD 7
|
3
+2.5%
|
2.40
|
USD 7
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
20,000
-20.0%
0.14
USD 2,800
|
20,000
-20.0%
|
0.14
|
USD 2,800
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
128,000
-46.5%
0.14
USD 17,920
|
128,000
-46.5%
|
0.14
|
USD 17,920
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
126,000
-36.9%
0.14
USD 17,640
|
126,000
-36.9%
|
0.14
|
USD 17,640
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
61,000
-45.2%
0.14
USD 8,540
|
61,000
-45.2%
|
0.14
|
USD 8,540
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
18,000
-45.0%
0.15
USD 2,700
|
18,000
-45.0%
|
0.15
|
USD 2,700
|
|
|
2023-12-13 |
2023-12-11 |
S
Sale
|
Davidow Robert L
Large shareholder
|
264,000
-27.9%
0.14
USD 36,960
|
264,000
-27.9%
|
0.14
|
USD 36,960
|
|
|
2023-09-12 |
2023-09-08 |
B
Purchase
|
Fortress Biotech, Inc.
Large shareholder
|
418,410
+68.1%
0.72
USD 301,255
|
418,410
+68.1%
|
0.72
|
USD 301,255
|
|
|
2023-09-12 |
2023-09-08 |
B
Purchase
|
ROSENWALD LINDSAY A MD
Non-Executive Director
|
348,675
+6178.9%
0.72
USD 251,046
|
348,675
+6178.9%
|
0.72
|
USD 251,046
|
|
|
2022-10-13 |
2022-10-11 |
S
Sale
|
InvaGen Pharmaceuticals, Inc.
Large shareholder
|
388,888
-100.0%
7.71
USD 2,999,882
|
388,888
-100.0%
|
7.71
|
USD 2,999,882
|
|
|
2021-05-07 |
2021-05-06 |
B
Purchase
|
Herskowitz Neil
Non-Executive Director
|
2,500
+1.9%
3.99
USD 9,975
|
2,500
+1.9%
|
3.99
|
USD 9,975
|
|
|
2020-08-21 |
2020-08-20 |
S
Sale
|
Vazzano Joseph Walter
Chief Financial Officer
Officer
|
3,840
-6.3%
12.13
USD 46,579
|
3,840
-6.3%
|
12.13
|
USD 46,579
|
|
|
2020-03-10 |
2020-03-10 |
B
Purchase
|
Vazzano Joseph Walter
Chief Financial Officer
Officer
|
1,889
+3.2%
7.94
USD 14,999
|
1,889
+3.2%
|
7.94
|
USD 14,999
|
|
|
2020-03-10 |
2020-03-09 |
B
Purchase
|
Vazzano Joseph Walter
Chief Financial Officer
Officer
|
100
+0.2%
7.97
USD 797
|
100
+0.2%
|
7.97
|
USD 797
|
|
|
2020-03-10 |
2020-03-09 |
B
Purchase
|
Vazzano Joseph Walter
Chief Financial Officer
Officer
|
1,400
+2.4%
7.99
USD 11,186
|
1,400
+2.4%
|
7.99
|
USD 11,186
|
|
|
2020-03-02 |
2020-02-27 |
B
Purchase
|
Herskowitz Neil
Non-Executive Director
|
2,400
+2.0%
8.20
USD 19,680
|
2,400
+2.0%
|
8.20
|
USD 19,680
|
|
|
2020-03-02 |
2020-02-26 |
B
Purchase
|
Herskowitz Neil
Non-Executive Director
|
161
+0.1%
8.73
USD 1,406
|
161
+0.1%
|
8.73
|
USD 1,406
|
|
